期刊
JOURNAL OF NEUROIMMUNE PHARMACOLOGY
卷 4, 期 2, 页码 175-189出版社
SPRINGER
DOI: 10.1007/s11481-009-9154-6
关键词
HIV; HIV-associated neurocognitive disorders; Alzheimer's disease; inflammation; autophagy; synapto-dendritic degeneration
资金
- NINDS NIH HHS [K08 NS055652, R01 NS045528-04, R01 NS045528, K08 NS055652-03, R01 NS073848] Funding Source: Medline
The human immunodeficiency virus (HIV) invades the central nervous system early in the course of infection and establishes a protected viral reservoir. However, neurocognitive consequences of HIV infection, known collectively as HIV-associated neurocognitive disorders (HAND), develop in only a small portion of infected patients. The precise mechanisms of pathogenesis involved in HIV-induced central nervous system injury are still not completely understood. In particular, most theories of HAND pathogenesis cannot account for either the selective vulnerability of specific neuronal populations to HIV-induced neurodegeneration or why only a subset of patients develop clinically detectable nervous system disease. Epidemiological and virological studies have identified a variety of host and viral factors that are associated with increased risk of developing HAND. Some host factors that predispose HIV-infected patients to HAND overlap with those associated with Alzheimer's disease (AD), suggesting the possibility that common pathogenic mechanisms may participate in both diseases. Here, we will review reports of host and viral factors associated with HAND and place these studies in the context of the data employed to support current theories regarding the molecular and cellular mechanisms that lead to HIV-induced neurodegeneration with additional focus on mechanisms common to AD pathogenesis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据